Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. [electronic resource]
Producer: 20071009Description: 638-47 p. digitalISSN:- 1547-5271
- 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester -- adverse effects
- Acetanilides -- pharmacology
- Action Potentials -- drug effects
- Analysis of Variance
- Animals
- Anti-Arrhythmia Agents -- pharmacology
- Calcium Channel Agonists -- adverse effects
- Disease Models, Animal
- Dogs
- Electrocardiography
- Endocardium -- cytology
- Enzyme Inhibitors -- pharmacology
- Heart Ventricles -- cytology
- Long QT Syndrome -- drug therapy
- Myocytes, Cardiac -- drug effects
- Patch-Clamp Techniques
- Pericardium -- cytology
- Piperazines -- pharmacology
- Ranolazine
- Tachycardia, Ventricular -- chemically induced
- Torsades de Pointes -- chemically induced
- Ventricular Premature Complexes -- chemically induced
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.